Delivery Order SPE2DB20D2014-SPE2DB24FD13R
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $4,375.66 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 31, 2023 and was awarded on July 28, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $71,902.18 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 21, 2023. The contract has an ultimate completion date of November 22, 2023 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Myrbetriq ER 50 MG Tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 10, 2022 with a ceiling value of $41,344.23. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 14, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC enables Amerisourcebergen to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $25,113.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 17, 2022 and was awarded on May 16, 2022. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $33,043.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 7, 2024, with an ultimate completion date of August 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop...
This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $5,921.75 and an ultimate completion date of April 19, 2022. The contract was awarded on April 18, 2022 and does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $21,341.03 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 5, 2022, with a completion date of July 6, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, valued at $10,892.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on May 18, 2023, with a completion date of May 19, 2023. This delivery order is part of...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,249.47, is a firm fixed-price delivery order with a completion date of November 8, 2022. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...